Two Sigma Advisers
ASMB icon

Two Sigma Advisers’s Assembly Biosciences ASMB Stock Holding History

Two Sigma Advisers’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,767
Closed -$27.2K – 2450
2023
Q4 		$27.2K Buy
2,767
+1,684
+155% +$16K ﹤0.01% 2434
2023
Q3 		$11.5K Sell
1,083
-159
-13% -$1.92K ﹤0.01% 2342
2023
Q2 		$17.1K Sell
1,242
-1,516
-55% -$18.6K ﹤0.01% 2329
2023
Q1 		$27.8K Sell
2,758
-359
-12% -$6.06K ﹤0.01% 2498
2022
Q4 		$48.6K Sell
3,117
-2,283
-42% -$39K ﹤0.01% 2366
2022
Q3 		$106K Sell
5,400
-2,658
-33% -$64.3K ﹤0.01% 2302
2022
Q2 		$203K Sell
8,058
-5,967
-43% -$137K ﹤0.01% 2274
2022
Q1 		$347K Sell
14,025
-21,250
-60% -$456K ﹤0.01% 2160
2021
Q4 		$986K Buy
35,275
+6,217
+21% +$204K ﹤0.01% 1565
2021
Q3 		$1.21M Sell
29,058
-34,042
-54% -$1.43M ﹤0.01% 1523
2021
Q2 		$2.94M Buy
63,100
+4,417
+8% +$219K 0.01% 1112
2021
Q1 		$3.24M Buy
58,683
+48,208
+460% +$3.2M 0.01% 1048
2020
Q4 		$760K Buy
10,475
+4,283
+69% +$503K ﹤0.01% 1695
2020
Q3 		$1.22M Sell
6,192
-933
-13% -$235K ﹤0.01% 1414
2020
Q2 		$1.99M Buy
7,125
+1,192
+20% +$278K 0.01% 1200
2020
Q1 		$1.06M Buy
5,933
+91
+2% +$19.5K ﹤0.01% 1458
2019
Q4 		$1.43M Sell
5,842
-725
-11% -$134K ﹤0.01% 1392
2019
Q3 		$775K Buy
6,567
+1,817
+38% +$275K ﹤0.01% 1545
2019
Q2 		$769K Buy
+4,750
New +$903K ﹤0.01% 1635
2018
Q2 		– Sell
-442
Closed -$260K – 2356
2018
Q1 		$260K Buy
+442
New +$274K ﹤0.01% 2062

Other funds holding ASMB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Advisers's ASMB Position: Q1 2024 in Review

Two Sigma Advisers sold out of Assembly Biosciences (ASMB) in Q1 2024, closing a stake of 2,767 shares — an estimated $27.2K sold.

Two Sigma Advisers first reported a position in ASMB in Q1 2018 and held it in 20 quarters. The position peaked at $3.24M in Q1 2021. 24 funds tracked by Wall St. Rank hold ASMB as of Q1 2024.

  • Two Sigma Advisers reported no remaining Assembly Biosciences position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 2,767 Assembly Biosciences shares in Q1 2024, an estimated $27.2K.
  • Two Sigma Advisers first reported a position in Assembly Biosciences in Q1 2018 and held it in 20 quarters.
  • Two Sigma Advisers's Assembly Biosciences position peaked at $3.24M in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2024.

Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.